Drug Chatter -- Tracking biopharma stock chatter

Profile for Spark Therapeutics, Inc. (ONCE)

« Back to company index

ONCE Chatter Timeline

Stock Ticker for ONCE

Most Active Tweeters for ONCE

UserTweets
@WatchlistN 8
@BioBounce 7
@registrarjourn 6
@WeekHerald 6
@OlympiaReport 5

Recent Tweets for ONCE

BioBounce @BioBounce
$ONCE hard stop remains 71.63
May 25th 2018, 4:05pm
dispatchtribune @dispatchtribune
Cantor Fitzgerald Reiterates $103.00 Price Target for Spark Therapeutics $ONCE https://t.co/Z1FxZXqVuy
May 25th 2018, 12:05pm
dailypoliticaln @dailypoliticaln
Spark Therapeutics $ONCE Given a $103.00 Price Target at Cantor Fitzgerald https://t.co/06EAWMJQK1
May 25th 2018, 12:05pm
zbiotech @zbiotech
$ONCE - 'not targeting a date-specific venue' for hemA update in Q3
May 25th 2018, 10:05am
ledgerzette @ledgerzette
Cantor Fitzgerald Reiterates $103.00 Price Target for Spark Therapeutics $ONCE https://t.co/Q0hd8g4X3t
May 25th 2018, 10:05am
BioBounce @BioBounce
$ONCE hard stop moves up to 71.63
May 25th 2018, 7:05am
ThisLincolnian @ThisLincolnian
Cantor Fitzgerald Weighs in on Spark Therapeutics’ FY2018 Earnings $ONCE https://t.co/QGp2DnbhpI
May 25th 2018, 6:05am
dakotafinancial @dakotafinancial
Spark Therapeutics $ONCE Rating Reiterated by Raymond James https://t.co/wxN7Bel3Nz
May 25th 2018, 3:05am
WatchlistN @WatchlistN
Cantor Fitzgerald Weighs in on Spark Therapeutics’ FY2018 Earnings $ONCE https://t.co/zJc6QKnnhg
May 25th 2018, 2:05am
WeekHerald @WeekHerald
Cantor Fitzgerald Research Analysts Raise Earnings Estimates for Spark Therapeutics $ONCE https://t.co/rkX6HWNVwq
May 24th 2018, 9:05am
WatchlistN @WatchlistN
Spark Therapeutics’ $ONCE Buy Rating Reiterated at Raymond James https://t.co/pIdFEdSJvg
May 24th 2018, 9:05am
dailypoliticaln @dailypoliticaln
Cantor Fitzgerald Research Analysts Raise Earnings Estimates for Spark Therapeutics $ONCE https://t.co/UqQ3U3ADt2
May 24th 2018, 8:05am
TickerReport @TickerReport
Cantor Fitzgerald Research Analysts Raise Earnings Estimates for Spark Therapeutics $ONCE https://t.co/Fkcoqz6NP2
May 24th 2018, 8:05am
ThisLincolnian @ThisLincolnian
Spark Therapeutics $ONCE Given a $103.00 Price Target by Cantor Fitzgerald Analysts https://t.co/50X1KfOin0
May 24th 2018, 6:05am
OlympiaReport @OlympiaReport
Spark Therapeutics $ONCE Given a $103.00 Price Target by Cantor Fitzgerald Analysts https://t.co/ogql0uDwnM
May 24th 2018, 5:05am
BioBounce @BioBounce
$ONCE now back over the 77.04 line and looking strong today. 82.61 up next https://t.co/OfkYJ3hptQ
May 23rd 2018, 10:05am
OlympiaReport @OlympiaReport
Spark Therapeutics’ $ONCE Buy Rating Reiterated at Raymond James https://t.co/Yzbi88xWSc
May 23rd 2018, 8:05am
WatchlistN @WatchlistN
Spark Therapeutics $ONCE Given a $103.00 Price Target at Cantor Fitzgerald https://t.co/hkkILHZ4Fe
May 23rd 2018, 5:05am
ZolmaxNews @ZolmaxNews
Cantor Fitzgerald Reiterates $103.00 Price Target for Spark Therapeutics $ONCE https://t.co/q23ewPsIX2
May 23rd 2018, 5:05am
TipRanksFeed @TipRanksFeed
4-star analyst Raju Prasad from William Blair rated $ONCE w/a Buy. Raju has a 71% success rate https://t.co/QUJrcjAIoS
May 23rd 2018, 3:05am
jjgiablue @jjgiablue
$ONCE-Barclays PT $85: SPK-9001's hemophilia p1/2 updates showed overall 98% ABR reduction and 97% AIR reduction, a… https://t.co/43MZKZTI0V
May 22nd 2018, 10:05pm
Gupta_Calling @Gupta_Calling
$ONCE TP $103 Cantor Fitzgerald Maintains Bullish View on Spark Therapeutics (ONCE) Following SPK-9001 Update https://t.co/21L5UntbA0
May 22nd 2018, 1:05pm
ConsumerFeed @ConsumerFeed
-$0.39 Earnings Per Share Expected for Spark Therapeutics $ONCE This Quarter https://t.co/sFyCu2Q0jv
May 22nd 2018, 12:05pm
WatchlistN @WatchlistN
$42.61 Million in Sales Expected for Spark Therapeutics $ONCE This Quarter https://t.co/rVToJIXjfY
May 22nd 2018, 12:05pm
registrarjourn @registrarjourn
$42.61 Million in Sales Expected for Spark Therapeutics $ONCE This Quarter https://t.co/tSj7dZyB7H
May 22nd 2018, 12:05pm
WeekHerald @WeekHerald
Zacks: Brokerages Expect Spark Therapeutics $ONCE to Announce -$0.39 EPS https://t.co/5bUYMGUzGx
May 22nd 2018, 12:05pm
evaluatepharma @evaluatepharma
#WFH2018 Spark keeps its haemophilia B gene therapy edge, for now - https://t.co/4CONAGUy8o via @EPVantage @ByMadeleineA $ONCE
May 22nd 2018, 12:05pm
DesertDweller93 @DesertDweller93
@ByMadeleineA @EPVantage The edge that $qure has over $once is that assuming 061 works as anticipated, qure owns 10… https://t.co/tHzkfdOxof
May 22nd 2018, 12:05pm
floszcrxl @floszcrxl
RT @JacobPlieth: @adar170 The $ONCE quotes are quite funny. Basically it's $PFE's problem now
May 22nd 2018, 12:05pm
matthewherper @matthewherper
"The $ONCE quotes are quite funny," Jacob says. "Basically it's $PFE's problem now." Jacob says. https://t.co/HWs0as0mMK
May 22nd 2018, 11:05am
JacobPlieth @JacobPlieth
@adar170 The $ONCE quotes are quite funny. Basically it's $PFE's problem now
May 22nd 2018, 11:05am
floszcrxl @floszcrxl
$QURE $ONCE Padua patents.... https://t.co/paYPe7xQdA https://t.co/3cV3W8hMuq
May 22nd 2018, 11:05am
EPVantage @EPVantage
RT @ByMadeleineA: $ONCE keeps its edge over $QURE in haemophilia B gene therapy, for now. More coverage from #WFH18 via @EPVantage https://…
May 22nd 2018, 11:05am
Socalsurfer3 @Socalsurfer3
Citi saying $ONCE shouldn't be trading higher on $bmrn Valrox data update, Spark F8 levels could also taper off (b… https://t.co/opYK3VaGxL
May 22nd 2018, 11:05am
ByMadeleineA @ByMadeleineA
$ONCE keeps its edge over $QURE in haemophilia B gene therapy, for now. More coverage from #WFH18 via @EPVantage https://t.co/O4wND6ca4p
May 22nd 2018, 11:05am
AmericanBanking @AmericanBanking
Spark Therapeutics $ONCE Given a $103.00 Price Target by Cantor Fitzgerald Analysts https://t.co/fJr1mue8Qg #stocks
May 22nd 2018, 9:05am
BioBounce @BioBounce
$ONCE hard stop still 70.66 - hanging out on the 77.04 line and trying to decide its next move. https://t.co/jdvPvuT7iO
May 21st 2018, 10:05am
noahgood @noahgood
@PRB51 It’s amazing and heartbreaking to see the patient videos - also $ONCE is working on a geneTx
May 20th 2018, 6:05pm
TheMarketsDaily @TheMarketsDaily
Zacks: Brokerages Expect Spark Therapeutics $ONCE Will Post Earnings of -$0.39 Per Share https://t.co/nqs9g1q3R5
May 20th 2018, 9:05am
registrarjourn @registrarjourn
Zacks: Brokerages Expect Spark Therapeutics $ONCE Will Post Earnings of -$0.39 Per Share https://t.co/KRrBeThNqS
May 20th 2018, 9:05am
ledgerzette @ledgerzette
Brokerages Expect Spark Therapeutics $ONCE Will Post Quarterly Sales of $42.61 Million https://t.co/K1EQP1I6uT
May 19th 2018, 6:05am
OlympiaReport @OlympiaReport
Brokerages Expect Spark Therapeutics $ONCE Will Post Quarterly Sales of $42.61 Million https://t.co/1fnTOubaT0
May 19th 2018, 3:05am
AmericanBanking @AmericanBanking
Brokerages Expect Spark Therapeutics $ONCE Will Post Quarterly Sales of $42.61 Million https://t.co/AZGbRxQGIS #stocks
May 19th 2018, 3:05am
Pharma_Intell @Pharma_Intell
RT @amandamicklus: “He’s in eighth grade, and he’s never seen the whiteboard before"...powerful story of $ONCE Luxturna first post-market p…
May 18th 2018, 3:05pm
RamonaDoyleMD @RamonaDoyleMD
RT @adamfeuerstein: A good news update. Jack Hogan, the first kid treated with $ONCE Luxturna gene therapy after its approval, is playing b…
May 17th 2018, 11:05pm
BioBounce @BioBounce
$ONCE hard stop still 70.66.
May 17th 2018, 5:05pm
amandamicklus @amandamicklus
“He’s in eighth grade, and he’s never seen the whiteboard before"...powerful story of $ONCE Luxturna first post-mar… https://t.co/EPoptqnu82
May 17th 2018, 5:05pm
WeekHerald @WeekHerald
Spark Therapeutics $ONCE – Research Analysts’ Recent Ratings Updates https://t.co/1RLdr4vB2T
May 17th 2018, 3:05pm
dispatchtribune @dispatchtribune
Spark Therapeutics $ONCE – Research Analysts’ Recent Ratings Updates https://t.co/5xy2DRd8Yn
May 17th 2018, 3:05pm
AmericanBanking @AmericanBanking
Spark Therapeutics $ONCE – Research Analysts’ Recent Ratings Updates https://t.co/Pyhkhb8jpF #stocks
May 17th 2018, 3:05pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.